News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

Pivotal Clinical Study to Establish the Safety and Effectiveness of the Use of BioTraceIO Lite for Assessment of Tissue Damage following Liver Tissue Ablation Procedures

Study Status:

Closed for enrollment

Contact Information:

(956) 362-2394

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

To demonstrate the safety and effectiveness of BioTraceIO Lite in estimating the area of primary and secondary tissue damage post-procedure in radiofrequency (RF) and microwave (MW) liver tissue ablation procedures

Information: 

Principal Investigator
Dr. Mario Moya
Co-PI
Edgar Lopez Pacheco
Sponsor
Techsomed
Type of Trial
Interventional
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram